Launched in 2004, The Paragraph Four Report® researches, compiles, and analyzes the universe of Paragraph IV Patent cases filed in the U.S. The research constantly tracks, monitors, and updates all PIV cases through completion and presents these data in easy-to-navigate databases. The research also includes Inter Partes Review proceedings and biosimilar BPCIA patent cases.

The Paragraph Four Report has become the standard for reliable PIV research which is the reason why so many pharmaceutical companies, supply chain, investors, law firms, and academia across four continents subscribe to 

For information regarding a subscription to The Paragraph Four Report, email us at .

The Paragraph Four Report,, and the PFOUR logo are registered trademarks of Parry Ashford Inc. • © Parry Ashford Inc. 2019